Quantcast

Latest Anti-diabetic drug Stories

2008-06-17 09:01:13

Akesis Pharmaceuticals, Inc. (OTCBB: AKES), an emerging diabetes drug-development company, today announced positive results of its preliminary analysis from its placebo-controlled Phase IIa trial designed to test the safety and efficacy of AKP-020, a novel vanadium compound, in patients with Type 2 diabetes. In this single blinded study seven type 2 diabetic subjects were dosed with AKP-020 and two with placebo for 28 days. Over the 28-day period, both placebo subjects showed an increase...

2008-06-16 18:00:07

Some people with type 2 diabetes can control the disease and avoid insulin injections by using multiple classes of oral medications, U.S. researchers say. Principal investigator Dr. Arthur Swislocki of the Veterans Affairs Northern California Health Care System in Martinez says oral diabetes medications help control blood glucose, or sugar, levels for years in people whose bodies still produce some insulin -- as many patients with type 2 diabetes do. Generally, both patients and...

2008-04-15 09:00:14

PARSIPPANY, NJ, April 15 /PRNewswire/ -- Daiichi Sankyo announced today that Welchol(TM) (colesevelam HCl) has been added to the American College of Endocrinology (ACE) and American Association of Clinical Endocrinologists (AACE) 2008 "Road Maps to Achieve Glycemic Control in Type 2 Diabetes Mellitus." The Road Maps are updated regularly by ACE/AACE to provide physicians with the latest and most comprehensive treatment options for their patients with type 2 diabetes mellitus. Welchol is the...

2008-03-17 06:00:06

By Kathleen Fackelmann Donald McEwen was driving on I-480 when he saw an ad on the back of a bus recruiting people for a study on diabetes. He picked up his cellphone almost immediately. "I was scared to death," he says now about the pain, fatigue and vision problems caused by his diabetes. "My health was so bad that I thought I would be not long for this world." McEwen, a salesman from Parma, Ohio, got into the study, took his medication and pushed his blood sugar from dangerously...

2008-02-26 06:00:00

Federal researchers who tried to reduce heart attacks among diabetics by driving their blood sugar to low levels found that more patients were dying instead. The finding, announced yesterday, prompted officials to halt part of a major study of diabetes and heart disease. Researchers said they don't know what caused the spike in deaths but said it can't be blamed on Avandia -- a diabetes medication linked last year to an increased risk of heart attacks -- even though some volunteers were...

2007-01-31 09:00:17

RESTON, Va., Jan. 31 /PRNewswire/ -- Millions of people suffer from the chronic pain and complications of autonomic neuropathy, a degenerative nerve disease. A new book suggests that this suffering can be effectively treated by raising blood sugar levels at key points. In doing so, Type 4 Diabetes raises the prospect that neuropathy, fibromyalgia and Alzheimer's may be all linked to diabetes as symptoms of the same problem with glucose metabolism. "Type 4 Diabetes: Elevated Insulin. Lower...

2006-11-08 03:00:10

By Kim, M J; Rolland, Y; Cepeda, O; Gammack, J K; Morley, J E Abstract Most persons with diabetes mellitus are over the age of 60 years. Males develop diabetes more commonly than females. Older diabetics tend to have both impaired insulin release as well as insulin resistance. In older persons diabetes mellitus is associated with decreased functional status and cognitive dysfunction. In general, older persons with diabetes are inclined to be underdiagnosed and undertreated. Managing...

2006-02-15 15:13:56

By Will Boggs, MD NEW YORK (Reuters Health) - Better metabolic control of type 2 diabetes can lead to improved "working memory" -- the type of memory people use to keep information in their minds for short-periods of time and to complete day-to-day activities. "Many of the patients with type 2 diabetes may have evidence of mild cognitive dysfunction," Dr. Christopher M. Ryan, from University of Pittsburgh School of Medicine, told Reuters Health. "Improving metabolic control and...

2005-11-21 12:08:05

By Susan Heavey WASHINGTON (Reuters) - An experimental diabetes drug that may increase the risk of congestive heart failure and death should not be allowed on the market despite initial support from U.S. regulators, a consumer group said on Monday. Public Citizen's Health Research Group called on the U.S. Food and Drug Administration to hold off approving Pargluva, made by Bristol-Myers Squibb Co. and Merck & Co Inc., without "at the very least" a five-year clinical safety...

2005-11-21 11:50:00

By Susan Heavey WASHINGTON -- An experimental diabetes drug that may increase the risk of congestive heart failure and death should not be allowed on the market despite initial support from U.S. regulators, a consumer group said on Monday. Public Citizen's Health Research Group called on the U.S. Food and Drug Administration to hold off approving Pargluva, made by Bristol-Myers Squibb Co. and Merck & Co Inc., without "at the very least" a five-year clinical safety study. The fate of the...


Word of the Day
tesla
  • The unit of magnetic flux density in the International System of Units, equal to the magnitude of the magnetic field vector necessary to produce a force of one newton on a charge of one coulomb moving perpendicular to the direction of the magnetic field vector with a velocity of one meter per second. It is equivalent to one weber per square meter.
This word is named for Nikola Tesla, the inventor, engineer, and futurist.